URVI PATEL: Open Payments
NPI 1255085783 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,676 in 146 payments from 18 companies in 2025. Trend: 2023 $2,437 · 2024 $2,318 · 2025 $2,676
Food & beverage: $2,591Education: $85
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $427 |
| UCB, Inc. | 19 | $318 |
| ABBVIE INC. | 20 | $316 |
| GENZYME CORPORATION | 7 | $293 |
| LEO Pharma Inc. | 12 | $276 |
| Novartis Pharmaceuticals Corporation | 12 | $233 |
| PFIZER INC. | 21 | $178 |
| Galderma Laboratories, L.P. | 12 | $164 |
| Lilly USA, LLC | 11 | $158 |
| Janssen Biotech, Inc. | 7 | $128 |
Products named: DUPIXENT, Bimzelx, COSENTYX, CIBINQO, RINVOQ, NEMLUVIO, TALTZ, ADBRY.
Industry payments across OK — which companies pay providers there.
